investordatabase.org

Vestal Point Capital, LP

vestalpoint.com Direct investor

Vestal Point Capital is an investment firm specializing in life sciences, managing a portfolio of securities across biotechnology, pharmaceuticals, medical devices, tools, and diagnostics sectors. It employs a research-driven approach with rigorous risk management.

Vestal Point Capital, LP is an investor headquartered in New York, United States. It invests directly in companies, in biotechnology, pharmaceuticals, medical devices and tools.

“We invest in companies where our proprietary insights into scientific or financial fundamentals reveal opportunities that the broader market may not fully recognize.”

Vestal Point Capital, LP, own website
Layer
Direct investor
Type
Other
Stage
Not applicable
Headquarters
New York, United States
Sectors
biotechnology, pharmaceuticals, medical devices, tools, diagnostics

Team, as Vestal Point Capital, LP publishes it

  • Ryan Wilder Managing Partner and Chief Investment Officer
  • Ilko Menkov Partner, COO and CCO
  • Charles Adams Research Analyst
  • Benjamin Carroll Chief Financial Officer
  • Tyler DeGeorge Trading Analyst
  • Marc Murphy Head Trader
  • Jack Peacock Research Analyst
  • Rebecca Wheat Office Manager
  • Christian Wilson Research Analyst
  • Hong Zheng Research Analyst, Ph.D.

Names and roles exactly as listed on vestalpoint.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Vestal Point Capital, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 5890 · added 2026-09-03 · link last verified 2026-09-21 · confidence high

Similar investors

Listed under